Status:
COMPLETED
Acceptance and Commitment Therapy, a Mindfulness-Based Approach for Treatment of Chronic Musculoskeletal Pain
Lead Sponsor:
University of New Hampshire
Collaborating Sponsors:
University of Texas at Austin
Conditions:
Chronic Musculoskeletal Disease
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Acceptance and Commitment Therapy (ACT) has been recognized as an effective, non-pharmacologic treatment for a variety of CP conditions. However, little is known about the neurologic mechanisms underl...
Detailed Description
Over 100 million Americans suffer from chronic pain (CP), which causes more disability than any other medical condition in the U.S. at a cost of $560-$635 billion per year. Opioid analgesics are frequ...
Eligibility Criteria
Inclusion
- greater than or equal to 18 years of age
- Chronic musculoskeletal pain duration for greater than or equal to 3 months
- Pain interference greater than or equal to 4 on Brief Pain Inventory (BPI; 0-10 scale)
- No known contraindication to participate
- Access to regular transportation
- No plans to move or become pregnant in the next 3 months
- MRI safe
- Personal cell phone with the ability to receive text messages and access web-based material (e.g. short surveys)
Exclusion
- Unstable medical condition, including a movement disorder, such as restless leg syndrome or Parkinson's disease, a neurological disorder such as Alzheimer's disease, history of stroke or brain lesion, a psychiatric disorder such as schizophrenia or bipolar disorder
- Significant cognitive impairment
- Pregnancy(a test must be conducted on each scan day)
- A recent history of: cancer, malignancy, accident or trauma, palliative care, acupuncture, chiropractic care, cognitive-based psychotherapy, other form of alternative care to treat pain condition
- Metal in the body of any sort - implants, pacemaker, pins, screws
Key Trial Info
Start Date :
August 31 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2020
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT04502992
Start Date
August 31 2018
End Date
June 15 2020
Last Update
August 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Communication Science and Disorders Research Laboratory, University of New Hampshier
Durham, New Hampshire, United States, 03824